Meramyl Hct

Hydrochlorothiazide / Ramipril, the active ingredient in Meramyl Hct, is a thiazide diuretic and ACE inhibitor presented as an oral tablet for oral use. It is indicated for the management of hypertension in adult patients.

GNH USA supplies Meramyl Hct as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Meramyl Hct is used in the treatment of cardiovascular conditions that benefit from combined diuretic and ACE‑inhibitor therapy.

Hypertension: lowers systolic and diastolic blood pressure in patients with primary hypertension. Heart failure: provides adjunctive blood‑pressure control and reduces fluid overload when combined with standard heart‑failure regimens. Post‑myocardial infarction: helps to improve long‑term cardiovascular outcomes by controlling blood pressure and reducing ventricular remodeling.

Common Side Effects: - Dizziness or light‑headedness, especially after the first dose. - Persistent dry cough. - Increased frequency of urination. - Mild headache. - Electrolyte disturbances such as low potassium or sodium. - Fatigue or general weakness.

Serious or Rare Side Effects: - Angioedema or severe swelling of the face, lips, tongue, or throat. - Anaphylactic reactions. - Severe dehydration or electrolyte imbalance. - Acute kidney injury or worsening renal function. - Hyperkalemia leading to cardiac arrhythmia. - Severe hypotension causing fainting or shock.

Before initiating therapy, clinicians should assess patient history and monitor relevant parameters. - Blood pressure monitoring: ensure target levels are achieved without excessive drop. - Renal function: check serum creatinine and eGFR periodically. - Electrolyte balance: monitor potassium and sodium levels, especially in patients on other diuretics. - Hypersensitivity: avoid in individuals with known allergy to ACE inhibitors or thiazide diuretics. - Elderly patients: start at lower dose and monitor for orthostatic hypotension. Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

When prescribing Meramyl Hct, consider potential drug‑drug interactions.

Major Interactions (Avoid): - Aliskiren in patients with diabetes or renal impairment. - Potassium‑sparing diuretics or supplements (risk of hyperkalemia). - NSAIDs (may blunt antihypertensive effect and impair renal function). - Lithium (increased lithium levels and toxicity). - Concurrent use of another ACE inhibitor or ARB (excessive renin‑angiotensin blockade).

Moderate Interactions (Monitor Closely): - Other antihypertensives (additive blood‑pressure lowering, monitor for hypotension). - Digoxin (diuretics may alter serum digoxin levels). - Antidiabetic agents (diuretic‑induced changes in glucose control). - Corticosteroids (may increase fluid retention). - Loop diuretics (enhanced electrolyte disturbances).